Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Morris

Showing results (1101-1110 of 1,207) with videos related to

Pageof 121
Sort By:
British Journal of Clinical Pharmacology|June 30, 2016
EUROmediCAT signal detection: a systematic method for identifying potential teratogenic medicationJohannes M Luteijn, Joan K Morris, Ester Garne, et al.
Cancer Discovery|October 13, 2016
Phase IB Study of Vemurafenib in Combination with Irinotecan and Cetuximab in Patients with Metastatic Colorectal Cancer with BRAFV600E MutationDavid S Hong, Van K Morris, Badi El Osta, et al.
Pediatric Research|January 24, 2025
Pediatric COVID-19 severity by SARS-CoV-2 lineage and vaccine status in Canada: an IMPACT studyDaniel S Farrar, Julie A Bettinger, Aaron J Campigotto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 29, 2017
Classifying Colorectal Cancer by Tumor Location Rather than Sidedness Highlights a Continuum in Mutation Profiles and Consensus Molecular SubtypesJonathan M Loree, Allan A L Pereira, Michael Lam, et al.
Archives of Disease in Childhood|February 19, 2024
Hospital care in the first 10 years of life of children with congenital anomalies in six European countries: data from the EUROlinkCAT cohort linkage studyJoan K Morris, Maria Loane, Charlotte Wahlich, et al.
JAMA Network Open|April 11, 2025
Risk Factors for Severe Disease Among Children Hospitalized With Respiratory Syncytial VirusNardin Kirolos, Haifa Mtaweh, Rohini R Datta, et al.
BMJ Open|July 27, 2023
Ethics and legal requirements for data linkage in 14 European countries for children with congenital anomaliesHugh Claridge, Joachim Tan, Maria Loane, et al.
Cancer|September 7, 2022
Cost effectiveness of treatment strategies for high risk prostate cancerRoman O Kowalchuk, Hayeon Kim, William S Harmsen, et al.
Plos One|August 30, 2023
Creating a population-based cohort of children born with and without congenital anomalies using birth data matched to hospital discharge databases in 11 European regions: Assessment of linkage success and data qualityMaria Loane, Joanne E Given, Joachim Tan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 28, 2020
Randomized Trial of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF-Mutant Metastatic Colorectal Cancer (SWOG S1406)Scott Kopetz, Katherine A Guthrie, Van K Morris, et al.
Pageof 121

Showing results (1101-1110 of 1,207) with videos related to

Sort By:
Pageof 121
British Journal of Clinical Pharmacology|June 30, 2016
EUROmediCAT signal detection: a systematic method for identifying potential teratogenic medicationJohannes M Luteijn, Joan K Morris, Ester Garne, et al.
Cancer Discovery|October 13, 2016
Phase IB Study of Vemurafenib in Combination with Irinotecan and Cetuximab in Patients with Metastatic Colorectal Cancer with BRAFV600E MutationDavid S Hong, Van K Morris, Badi El Osta, et al.
Pediatric Research|January 24, 2025
Pediatric COVID-19 severity by SARS-CoV-2 lineage and vaccine status in Canada: an IMPACT studyDaniel S Farrar, Julie A Bettinger, Aaron J Campigotto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 29, 2017
Classifying Colorectal Cancer by Tumor Location Rather than Sidedness Highlights a Continuum in Mutation Profiles and Consensus Molecular SubtypesJonathan M Loree, Allan A L Pereira, Michael Lam, et al.
Archives of Disease in Childhood|February 19, 2024
Hospital care in the first 10 years of life of children with congenital anomalies in six European countries: data from the EUROlinkCAT cohort linkage studyJoan K Morris, Maria Loane, Charlotte Wahlich, et al.
JAMA Network Open|April 11, 2025
Risk Factors for Severe Disease Among Children Hospitalized With Respiratory Syncytial VirusNardin Kirolos, Haifa Mtaweh, Rohini R Datta, et al.
BMJ Open|July 27, 2023
Ethics and legal requirements for data linkage in 14 European countries for children with congenital anomaliesHugh Claridge, Joachim Tan, Maria Loane, et al.
Cancer|September 7, 2022
Cost effectiveness of treatment strategies for high risk prostate cancerRoman O Kowalchuk, Hayeon Kim, William S Harmsen, et al.
Plos One|August 30, 2023
Creating a population-based cohort of children born with and without congenital anomalies using birth data matched to hospital discharge databases in 11 European regions: Assessment of linkage success and data qualityMaria Loane, Joanne E Given, Joachim Tan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 28, 2020
Randomized Trial of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF-Mutant Metastatic Colorectal Cancer (SWOG S1406)Scott Kopetz, Katherine A Guthrie, Van K Morris, et al.
Pageof 121